YAP1 and breast carcinoma: In glioblastoma and breast cancer cells, mutant TP53 establish its oncogenic activity by WASP-interacting protein (WIP), and WIP stabilizes YAP/TAZ thereby sustaining the cancer stem cell survival and oncogenic function [43].